← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2011First marketed drug
Feb 1, 2013First NDA
Feb 1, 2013Last known activity
Jul 1, 2011
Acquired by Horizon Pharma → Amgen on Jan 1, 2015
Timeline
2000s
- Jan 1, 2006
Hyperion Therapeutics— Founded
2010s
- Feb 1, 2013
glycerol phenylbutyrate— NDA Organization
- Apr 24, 2014
Andromeda Biotech Ltd.— Acquired
- Jan 1, 2015
Horizon Pharma— Acquired By
Drugs by trial phase (2 distinct, 5 trials)
Phase 3 (1 own, 1 via acquisition)
Indications
Approved for
Studied for
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (1)
- NCT01347073Study chairPhase 3Jul 1, 2011
Details
- Founded
- South San Francisco, CA, US Jan 1, 2006
- First NDA
- Feb 1, 2013
- Last known activity
- Jul 1, 2011
Designations held
- Orphan drug
- Fast track
Notes
Acquired by Horizon Pharma 30 Mar 2015